相关实验视频
Updated: Jul 7, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
125
了解微生物组在自身免疫性类风湿性疾病中的作用
Abhimanyu Amarnani1, Gregg J Silverman1
1Department of Medicine, NYU Grossman School of Medicine, New York, NY USA.
Rheumatology and immunology research
|December 21, 2023
概括
肠道微生物群影响自身免疫性类风湿性疾病,如类风湿性关节炎和狼. 恢复肠道健康可能为这些疾病提供新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 类风湿病学 类风湿病学
背景情况:
- 肠道微生物组在免疫系统调节中起着至关重要的作用.
- 自身免疫性类风湿性疾病涉及复杂的免疫失调.
- 新出现的证据将肠道失调与各种自身免疫性疾病联系起来.
研究的目的:
- 审查当前对肠道微生物组在自身免疫性风湿性疾病中的作用的理解.
- 探索肠道微生物影响疾病发病的机制.
- 确定未来的研究方向和潜在的治疗干预措施.
主要方法:
- 关于肠道微生物组和自身免疫性风湿性疾病的研究文献综述.
- 分析证据,将肠道疾病与类风湿性关节炎,全身性红斑狼,脊髓关节病,Sjogren综合征和全身性硬化症联系起来.
- 综合当前关于微生物组与免疫系统相互作用的知识.
主要成果:
- 肠道微生物组组成和功能的改变与类风湿性关节炎和全身性红斑狼有关.
- 增加的肠道透性和微生物代谢物有助于这些疾病的全身免疫激活.
- 越来越多的证据表明,肠道失调有助于脊髓关节病变和Sjogren综合征的发病,有系统性硬化症的初步数据.
结论:
- 肠道微生物组是自身免疫性类风湿性疾病的发展和进展的一个重要因素.
- 了解复杂的微生物群-免疫系统相互作用对于治疗进步至关重要.
- 旨在恢复肠道微生物群平衡的策略对治疗自身免疫性风湿性疾病具有前途.
相关概念视频
Autoimmune Disorders
446
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
446
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
168
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168
Inflammatory Bowel Disease IV: Pharmacological Management
128
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
128
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
141
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
141

